{"id":"sk-1403","safety":{"commonSideEffects":[{"rate":null,"effect":"Unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by binding to the molecular target, which results in the desired therapeutic effect.","oneSentence":"SK-1403 is a small molecule drug that targets the molecular target.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:34:58.215Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Unknown"}]},"trialDetails":[{"nctId":"NCT03626948","phase":"PHASE3","title":"SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis","status":"COMPLETED","sponsor":"Sanwa Kagaku Kenkyusho Co., Ltd.","startDate":"2018-09-13","conditions":"Secondary Hyperparathyroidism","enrollment":157},{"nctId":"NCT03801980","phase":"PHASE3","title":"Phase 3 Study of SK-1403","status":"COMPLETED","sponsor":"Sanwa Kagaku Kenkyusho Co., Ltd.","startDate":"2019-01-21","conditions":"Secondary Hyperparathyroidism","enrollment":153},{"nctId":"NCT03226171","phase":"PHASE2","title":"Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism","status":"COMPLETED","sponsor":"Sanwa Kagaku Kenkyusho Co., Ltd.","startDate":"2017-06-20","conditions":"Secondary Hyperparathyroidism","enrollment":58}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"SK-1403","genericName":"SK-1403","companyName":"Sanwa Kagaku Kenkyusho Co., Ltd.","companyId":"sanwa-kagaku-kenkyusho-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SK-1403 is a small molecule drug that targets the molecular target. Used for Unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}